Glovista Investments Has Lifted Dr Reddys Labs LTD (RDY) Stake by $996,151; Stock Rose; As Masimo (MASI) Market Value Rose, Tudor Investment Et Al Has Trimmed Its Holding

Dr. Reddy's Laboratories Limited (NYSE:RDY) Logo

Tudor Investment Corp Et Al decreased its stake in Masimo Corporation (MASI) by 93.07% based on its latest 2018Q4 regulatory filing with the SEC. Tudor Investment Corp Et Al sold 45,825 shares as the company’s stock rose 21.63% with the market. The hedge fund held 3,413 shares of the electromedical & electrotherapeutic apparatus company at the end of 2018Q4, valued at $366,000, down from 49,238 at the end of the previous reported quarter. Tudor Investment Corp Et Al who had been investing in Masimo Corporation for a number of months, seems to be less bullish one the $6.56 billion market cap company. The stock decreased 7.10% or $9.39 during the last trading session, reaching $122.95. About 637,245 shares traded or 53.96% up from the average. Masimo Corporation (NASDAQ:MASI) has risen 62.81% since April 17, 2018 and is uptrending. It has outperformed by 58.44% the S&P500. Some Historical MASI News: 10/04/2018 – MASIMO CORP – RAD-97 IS NOW AVAILABLE BOTH WITHIN AND OUTSIDE UNITED STATES IN THREE CONFIGURATIONS; 01/05/2018 – Masimo O3® Regional Oximetry and SedLine® Brain Function Monitoring Power Two Investigations into Postoperative Delirium; 23/04/2018 – Investor Expectations to Drive Momentum within CVB Financial, New Senior Investment Group, EXTRACTION O&G, Masimo, Timken Steel; 10/04/2018 – Masimo Presenting at Deutsche Bank Health Care Conference May 8; 14/05/2018 – New Study Investigates the Economic Impact and Utility of Continuous Noninvasive Hemoglobin Measurement with Masimo SpHb® in; 09/03/2018 – MASIMO CORP MASI.O : BARCLAYS STARTS WITH OVERWEIGHT RATING; $97 TARGET PRICE; 02/05/2018 – Masimo 1Q Rev $213M; 07/05/2018 – Robeco Institutional Asset Mgmt Exits Position in Masimo; 15/05/2018 – Healthcor Management Buys New 1.1% Position in Masimo; 07/05/2018 – Robeco Institutional Adds Worldpay, Exits Masimo: 13F

Glovista Investments Llc increased its stake in Dr Reddys Labs Ltd (RDY) by 153.59% based on its latest 2018Q4 regulatory filing with the SEC. Glovista Investments Llc bought 26,923 shares as the company’s stock rose 0.97% with the market. The institutional investor held 44,452 shares of the major pharmaceuticals company at the end of 2018Q4, valued at $1.68M, up from 17,529 at the end of the previous reported quarter. Glovista Investments Llc who had been investing in Dr Reddys Labs Ltd for a number of months, seems to be bullish on the $6.62 billion market cap company. The stock increased 0.42% or $0.17 during the last trading session, reaching $40.17. About 137,152 shares traded. Dr. Reddy's Laboratories Limited (NYSE:RDY) has risen 9.79% since April 17, 2018 and is uptrending. It has outperformed by 5.42% the S&P500. Some Historical RDY News: 22/05/2018 – Dr. Reddy’s Laboratories posts surprise fall in profit amid US pricing pressure; 29/03/2018 – DR.REDDY’S LABORATORIES LTD REDY.NS – MUKHERJEE WILL BE SUCCEEDED BY EREZ ISRAELI, FORMER PRESIDENT & CEO OF ENZYMOTEC; 24/05/2018 – J&J JANSSEN SUES DR. REDDY’S, LAURUS OVER PREZISTA PATENTS; 10/04/2018 – DR.REDDY’S TO CONSIDER FY18 RESULTS & DIVIDEND ON MAY 22, 2018; 25/05/2018 – DR.REDDY’S LABORATORIES LTD REDY.NS – FILED LAWSUIT AGAINST PERRIGO UK FINCO, PERRIGO ISRAEL PHARMACEUTICALS, AND TARO PHARMACEUTICALS; 09/04/2018 – Mezzion Wins Appellate Jurisdiction Fight Against Dr. Reddy’s; 25/05/2018 – DR.REDDY’S UNIT FILES LAWSUIT AGAINST PERRIGO, TARO FOR SERNIVO; 02/04/2018 – DR.REDDY’S LABORATORIES – UPON APPROVAL, PRODUCT WILL BE COMMERCIALISED BY PROMIUS PHARMA; 21/03/2018 – FDA: Form 483: Dr. Reddy’s Laboratories Ltd., 3/9/2018; 06/03/2018 Live: Sensex, Nifty Trade Flat; Tata Motors, Dr Reddy’s Top Gainers

More notable recent Masimo Corporation (NASDAQ:MASI) news were published by: Nasdaq.com which released: “Thermo Fisher to Buy Brammer Bio, Tightens Gene Therapy Grip – Nasdaq” on March 25, 2019, also Nasdaq.com with their article: “Fresenius Medical to Make Huge Investments, Competition Rife – Nasdaq” published on March 26, 2019, Nasdaq.com published: “Medtronic plc (MDT) Ex-Dividend Date Scheduled for March 21, 2019 – Nasdaq” on March 20, 2019. More interesting news about Masimo Corporation (NASDAQ:MASI) were released by: Nasdaq.com and their article: “Quest Diagnostics Grows on New Pacts Amid Reimbursement Issue – Nasdaq” published on March 25, 2019 as well as Nasdaq.com‘s news article titled: “Why Masimo (MASI) Could Beat Earnings Estimates Again – Nasdaq” with publication date: January 28, 2019.

Investors sentiment increased to 1.07 in Q4 2018. Its up 0.19, from 0.88 in 2018Q3. It improved, as 22 investors sold MASI shares while 111 reduced holdings. 49 funds opened positions while 93 raised stakes. 44.42 million shares or 6.84% more from 41.58 million shares in 2018Q3 were reported. Nordea Invest Mngmt Ab, a Sweden-based fund reported 38,139 shares. Congress Asset Communication Ma holds 0.04% or 27,523 shares. Eam Ltd Liability Corp invested in 0.49% or 16,697 shares. Natixis has 0.08% invested in Masimo Corporation (NASDAQ:MASI). Shell Asset Mgmt holds 0.03% or 9,914 shares. Sumitomo Mitsui Asset Limited holds 0.07% in Masimo Corporation (NASDAQ:MASI) or 33,894 shares. Profund Advisors Ltd Liability Com has invested 0.03% in Masimo Corporation (NASDAQ:MASI). Products Ptnrs Llc stated it has 54,509 shares or 0.33% of all its holdings. Utah Retirement Systems holds 0.02% of its portfolio in Masimo Corporation (NASDAQ:MASI) for 8,500 shares. National Bank Of Mellon Corp, a New York-based fund reported 599,566 shares. Covington Cap Mngmt invested in 100 shares or 0% of the stock. Fund Mgmt Sa invested in 0.05% or 47,439 shares. Deutsche Financial Bank Ag owns 289,580 shares or 0.02% of their US portfolio. Point72 Asset Ltd Partnership invested in 0.06% or 105,700 shares. Pub Employees Retirement Association Of Colorado, Colorado-based fund reported 10,564 shares.

Since November 1, 2018, it had 0 insider buys, and 8 insider sales for $7.92 million activity. $240,000 worth of Masimo Corporation (NASDAQ:MASI) was sold by Coleman Jon. Sampath Anand had sold 30,000 shares worth $3.30M on Wednesday, November 28. 5 shares were sold by KIANI JOE E, worth $467.

Tudor Investment Corp Et Al, which manages about $21.89 billion and $5.06 billion US Long portfolio, upped its stake in Nuance Communications Inc (NASDAQ:NUAN) by 84,554 shares to 200,404 shares, valued at $2.65M in 2018Q4, according to the filing. It also increased its holding in Goodyear Tire And Rubber Company (NASDAQ:GT) by 123,835 shares in the quarter, for a total of 189,295 shares, and has risen its stake in Hcp Inc (NYSE:HCP).

Analysts await Masimo Corporation (NASDAQ:MASI) to report earnings on May, 1. They expect $0.75 EPS, 0.00% or $0.00 from last year’s $0.75 per share. MASI’s profit will be $40.02M for 40.98 P/E if the $0.75 EPS becomes a reality. After $0.83 actual EPS reported by Masimo Corporation for the previous quarter, Wall Street now forecasts -9.64% negative EPS growth.

More notable recent Dr. Reddy's Laboratories Limited (NYSE:RDY) news were published by: Seekingalpha.com which released: “Dr. Reddy’s Laboratories Limited 2019 Q3 – Results – Earnings Call Slides – Seeking Alpha” on February 01, 2019, also Benzinga.com with their article: “Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results – Benzinga” published on February 05, 2019, Seekingalpha.com published: “Teva’s soft outlook pressures generic peers – Seeking Alpha” on February 13, 2019. More interesting news about Dr. Reddy's Laboratories Limited (NYSE:RDY) were released by: Seekingalpha.com and their article: “Dr. Reddy’s launches Omeprazole, 20mg in U.S. – Seeking Alpha” published on December 11, 2018 as well as Benzinga.com‘s news article titled: “Daily Biotech Pulse: Advaxis Offering, Roche’s Spark Tender Offer Extended, Ascendis Earnings – Benzinga” with publication date: April 03, 2019.

Glovista Investments Llc, which manages about $940.85M and $353.86 million US Long portfolio, decreased its stake in Ishares Inc (TUR) by 22,986 shares to 25,164 shares, valued at $621,000 in 2018Q4, according to the filing. It also reduced its holding in Etfis Ser Tr I by 78,572 shares in the quarter, leaving it with 457,928 shares, and cut its stake in Ishares Inc (ECH).

Masimo Corporation (NASDAQ:MASI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.